May 11, 2015
PLEASANTON, Calif. -- Diagnostic BioSystems, an innovator of immunohistochemistry (IHC) solutions in the life science research and anatomic pathology markets, announced it has completed its growth capital financing with BroadOak Capital Partners, a life sciences focused merchant bank. The proceeds will be used to support the company's recent expansion into its new facility as well [...]
Implant Sciences Continues to Innovate – Granted Three More U.S. Patents for Trace Detection
May 11, 2015
WILMINGTON, Mass. -- Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the company has been granted three new patents by the U.S. Patent and Trademark Office. The patents, captioned "Non-Radioactive Ion Source Using High Energy Electrons", "Chemical Analysis Using [...]
Optimised Solid Phase Extraction of Polar Compounds
May 11, 2015
Porvair Sciences offers a range of products that enable optimised Solid Phase Extraction (SPE) of polar compounds. This includes a new C18 silica packed Microlute™ plate, vacuum manifolds, collection plates and solvent evaporators all designed to streamline your sample preparation. The new C18 Microlute plate offers good separation of a wide range of polar compounds [...]
May 11, 2015
FREMONT, California -— WaferGen Bio-systems, Inc. (NASDAQ: WGBS) announced today that the Company has appointed Rolland D. Carlson, Ph.D., President & CEO, effective immediately. Dr. Carlson assumes this role from Ivan Trifunovich, Ph.D., who has served as President & CEO of WaferGen since March 2012. Dr. Trifunovich has been appointed Executive Chairman of WaferGen. “With [...]
May 9, 2015
Albuquerque, New Mexico -- IntelliCyt Corporation, a leading developer of integrated solutions that accelerate drug discovery and life science research, today announced the launch of the iQue® Screener PLUS. The iQue Screener platform is an integrated instrument, software, and reagent system that enhances the screening workflow from sample preparation through results. It enables rapid, high [...]
FLUIDIGM APPOINTS STEVE MCPHAIL GM OF PRODUCTION GENOMICS
May 7, 2015
SOUTH SAN FRANCISCO, Calif. -– Fluidigm Corporation (NASDAQ:FLDM) has recruited industry veteran Steven C. McPhail to lead its new organization specifically focused on serving its production genomics customers. Production genomics remains a key strategic opportunity for Fluidigm to diversify the company’s product lines and end-customer mix. “For years, production genomics has been a growth driver [...]
Arrayit and USDA Expanding Patent Protection for Food Safety Testing Worldwide
May 7, 2015
SUNNYVALE, CA -- The ongoing Cooperative Research and Development Agreement (CRADA) between Arrayit Corporation (ARYC) and the United States Department of Agriculture (USDA), "Rapid and Cost Effective Detection Technologies for Noroviruses and other Foodborne Pathogens," entitles Arrayit to an exclusive license to commercialize the technology. Much of the food consumed in the United States, including [...]
May 7, 2015
LEXINGTON, Mass. -– N-of-One, Inc., the leader in clinical interpretation for precision medicine in oncology, today announced that it has signed a business partner agreement with Affymetrix, a leading provider of DNA microarrays. Under this agreement, N-of-One will provide copy number variation (CNV) analysis interpretation for Affymetrix OncoScan assay customers. Financial terms of the agreement [...]
May 7, 2015
Framingham, MA — SCIEX, a global leader in life science analytical technologies, has announced that Dr. Gyula Vigh, Emeritus Professor of Chemistry and inaugural holder of the Gradipore Chair in Separation Science at Texas A&M University was named the recipient of the Arnold O. Beckman Award for Outstanding Scientific Achievements in the field of electrodriven [...]
May 7, 2015
LEXINGTON, Mass. --N-of-One, Inc., the leader in clinical interpretation for precision medicine in oncology, today announced that it has signed a business partner agreement with Affymetrix, a leading provider of DNA microarrays. Under this agreement, N-of-One will provide copy number variation (CNV) analysis interpretation for Affymetrix OncoScan assay customers. Financial terms of the agreement are [...]
